Rajalekshmy Shyam

Dr. Rajalekshmy Shyam

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
PBPaul Bernstein
Paul Bernstein
BLBinxing Li
Binxing Li
PVPreejith Vachali
Preejith Vachali
AGAruna Gorusupudi
Aruna Gorusupudi
RSRajalekshmy Shyam
Rajalekshmy Shyam
John NolanJohn Nolan
John Nolan

5 September 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RSRajalekshmy Shyam
Rajalekshmy Shyam
AGAruna Gorusupudi
Aruna Gorusupudi
KNKelly Nelson
Kelly Nelson
MHMartin P. Horvath
Martin P. Horvath
PBPaul Bernstein
Paul Bernstein
Significance: Carotenoids are plant-derived pigment molecules that cannot be synthesized de novo by higher organisms. These physiologically relevant compounds function as potent antioxidants and light screening compounds, and their supplementation has been shown to ameliorate the progression of such diseases as age-related macular degeneration. Hundreds of carotenoids are present in the plant world, but the primate macula contains only three: lutein, zeaxanthin, and meso -zeaxanthin. The presence of meso -zeaxanthin in the foveal region of primates is an unexplained phenomenon, given its lack of dietary sources. We show that RPE65 is responsible for the conversion of lutein to meso -zeaxanthin in vertebrates, a unique role for RPE65 in carotenoid metabolism beyond its well-known retinoid isomerohydrolase function in the vertebrate visual cycle.

1 February 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XSXiang Shen
Xiang Shen
HYHongyu Ying
Hongyu Ying
YQYe Qiu
Ye Qiu
JPJeong-Seok Park
Jeong-Seok Park
RSRajalekshmy Shyam
Rajalekshmy Shyam
BYBeatrice Y. J. T. Yue
Beatrice Y. J. T. Yue
Optineurin is a gene linked to amyotrophic lateral sclerosis, Paget disease of bone, and glaucoma, a major blinding disease. Mutations such as E50K were identified in glaucoma patients. We investigated herein the involvement of ubiquitin-proteasome pathway (UPP) and autophagy, two major routes for protein clearance, in processing of optineurin in a retinal ganglion cell model line RGC5 and neuronal PC12 cells. It was found that the endogenous optineurin level in neuronal cells was increased by treatment of proteasomal inhibitor but not by autophagic and lysosomal inhibitors. Multiple bands immunoreactive to anti-ubiquitin were seen in the optineurin pulldown, indicating that optineurin was ubiquitinated. In cells overexpressing wild type and E50K optineurin, the level of the proteasome regulatory β5 subunit (PSMB5, indicative of proteasome activity) was reduced, whereas that for autophagy marker microtubule-associated protein 1 light chain 3 was enhanced compared with controls. Autophagosome formation was detected by electron microscopy. The foci formed after optineurin transfection were increased upon treatment of an autophagic inhibitor but were decreased by treatment of an inducer, rapamycin. Moreover, the level of optineurin-triggered apoptosis was reduced by rapamycin. This study thus provides compelling evidence that in a normal homeostatic situation, the turnover of endogenous optineurin involves mainly UPP. When optineurin is up-regulated or mutated, the UPP function is compromised, and autophagy comes into play. A decreased PSMB5 level and an induced autophagy were also demonstrated in vivo in retinal ganglion cells of E50K transgenic mice, validating and making relevant the in vitro findings.

12 July 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BPBumChan Park
BumChan Park
HYHongyu Ying
Hongyu Ying
XSXiang Shen
Xiang Shen
JPJeong-Seok Park
Jeong-Seok Park
YQYe Qiu
Ye Qiu
BYBeatrice Y. J. T. Yue
Beatrice Y. J. T. Yue
Glaucoma is a major blinding disease characterized by progressive loss of retinal ganglion cells (RGCs) and axons. Optineurin is one of the candidate genes identified so far. A mutation of Glu50 to Lys (E50K) has been reported to be associated with a more progressive and severe disease. Optineurin, known to interact with Rab8, myosin VI and transferrin receptor (TfR), was speculated to have a role in protein trafficking. Here we determined whether, and how optineurin overexpression and E50K mutation affect the internalization of transferrin (Tf), widely used as a marker for receptor-mediated endocytosis. Human retinal pigment epithelial (RPE) and rat RGC5 cells transfected to overexpress wild type optineurin were incubated with Texas Red-Tf to evaluate Tf uptake. Granular structures or dots referred to as foci formed in perinuclear regions after transfection. An impairment of the Tf uptake was in addition observed in transfected cells. Compared to overexpression of the wild type, E50K mutation yielded an increased foci formation and a more pronounced defect in Tf uptake. Co-transfection with TfR, but not Rab8 or myosin VI, construct rescued the optineurin inhibitory effect, suggesting that TfR was the factor involved in the trafficking phenotype. Forced expression of both wild type and E50K optineurin rendered TfR to colocalize with the foci. Surface biotinylation experiments showed that the surface level of TfR was also reduced, leading presumably to an impeded Tf uptake. A non-consequential Leu157 to Ala (L157A) mutation that displayed much reduced foci formation and TfR binding had normal TfR distribution, normal surface TfR level and normal Tf internalization. The present study demonstrates that overexpression of wild type optineurin results in impairment of the Tf uptake in RPE and RGC5 cells. The phenotype is related to the optineurin interaction with TfR. Our results further indicate that E50K induces more dramatic effects than the wild type optineurin, and is thus a gain-of-function mutation. The defective protein trafficking may be one of the underlying bases why glaucoma pathology develops in patients with E50K mutation.

1 September 2019 in Redox Biology
Verified
Journal Article
Open access
DODiego G. Ogando
Diego G. Ogando
MCMoonjung Choi
Moonjung Choi
RSRajalekshmy Shyam
Rajalekshmy Shyam
SLShimin Li
Shimin Li
JAJoseph A.
Joseph A.
SLC4A11 is a NH3 sensitive membrane transporter with H+ channel-like properties that facilitates Glutamine catabolism in Human and Mouse corneal endothelium (CE). Loss of SLC4A11 activity induces oxidative stress and cell death, resulting in Congenital Hereditary Endothelial Dystrophy (CHED) with corneal edema and vision loss. However, the mechanism by which SLC4A11 prevents ROS production and protects CE is unknown. Here we demonstrate that SLC4A11 is localized to the inner mitochondrial membrane of CE and SLC4A11 transfected PS120 fibroblasts, where it acts as an NH3-sensitive mitochondrial uncoupler that enhances glutamine-dependent oxygen consumption, electron transport chain activity, and ATP levels by suppressing damaging Reactive Oxygen Species (ROS) production. In the presence of glutamine, Slc4a11-/- (KO) mouse CE generate significantly greater mitochondrial superoxide, a greater proportion of damaged depolarized mitochondria, and more apoptotic cells than WT. KO CE can be rescued by MitoQ, reducing NH3 production by GLS1 inhibition or dimethyl αKetoglutarate supplementation, or by BAM15 mitochondrial uncoupling. Slc4a11 KO mouse corneal edema can be partially reversed by αKetoglutarate eye drops. Moreover, we demonstrate that this role for SLC4A11 is not specific to CE cells, as SLC4A11 knockdown in glutamine-addicted colon carcinoma cells reduced glutamine catabolism, increased ROS production, and inhibited cell proliferation. Overall, our studies reveal a unique metabolic mechanism that reduces mitochondrial oxidative stress while promoting glutamine catabolism.

1 November 2017 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
RSRajalekshmy Shyam
Rajalekshmy Shyam
PVPreejith Vachali
Preejith Vachali
AGAruna Gorusupudi
Aruna Gorusupudi
KNKelly Nelson
Kelly Nelson
PBPaul Bernstein
Paul Bernstein